REVELATION BIOSCIENCES INC - COM NEW (REVB)

CUSIP: 76135L309

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / COM NEW
Total 13F shares
806,006
Share change
+806,006
Total reported value
$1,047,808
Price per share
$1.30
Number of holders
10
Value change
+$1,047,808
Number of buys
10

Quarterly Holders Quick Answers

What is CUSIP 76135L309?
CUSIP 76135L309 identifies REVB - REVELATION BIOSCIENCES INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of REVELATION BIOSCIENCES INC - COM NEW (REVB) as of Q1 2023

As of 31 Mar 2023, REVELATION BIOSCIENCES INC - COM NEW (REVB) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 806,006 shares. The largest 10 holders included Anson Funds Management LP, SABBY MANAGEMENT, LLC, Walleye Capital LLC, Hudson Bay Capital Management LP, AXA S.A., Altium Capital Management LP, CVI Holdings, LLC, UBS Group AG, MORGAN STANLEY, and WELLS FARGO & COMPANY/MN. This page lists 10 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.